Results 11 to 20 of about 221,594 (183)

Pneumococcal vaccines [PDF]

01-Pneumococcal-Poehling-508 ...

core   +34 more sources

Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly

Risk Management and Healthcare Policy, 2018
Ger T Rijkers,1,2 Laura IE Yousif,1 Simone MC Spoorenberg,3 Frans J van Overveld1 1Department of Science, University College Roosevelt, Middelburg, the Netherlands; 2Department of Medical Microbiology and Immunology, St. Antonius Hospital ...
Rijkers GT, Yousif LIE, Spoorenberg SMC, van Overveld FJ   +3 more
doaj   +1 more source

The COVID-19 pandemic increased the demand for pneumococcal vaccination in Japan

Human Vaccines & Immunotherapeutics, 2021
Although routine vaccinations in children decreased during the coronavirus disease 2019 (COVID-19) pandemic, pneumococcal vaccine coverage in older adults has remained unknown.
Akira Komori, Hirotake Mori, Toshio Naito   +2 more
doaj   +1 more source

Evaluation of a phased pneumococcal conjugate vaccine introduction in Mongolia using enhanced pneumonia surveillance and community carriage surveys: a study protocol for a prospective observational study and lessons learned

BMC Public Health, 2019
Background Streptococcus pneumoniae causes substantial morbidity and mortality among children. The introduction of pneumococcal conjugate vaccines (PCV) has the potential to dramatically reduce disease burden.
S. F. La Vincente, C. von Mollendorf, M. Ulziibayar, C. Satzke, L. Dashtseren, K. K. Fox, E. M. Dunne, C. D. Nguyen, J. de Campo, M. de Campo, H. Thomson, G. Surenkhand, S. Demberelsuren, S. Bujinlkham, L. A. H. Do, D. Narangerel, T. Cherian, T. Mungun, E. K. Mulholland   +18 more
doaj   +1 more source

30-Minute Highly Multiplexed VaxArray Immunoassay for Pneumococcal Vaccine Antigen Characterization

Vaccines, 2022
Pneumonia accounts for over 20% of deaths worldwide in children aged 1 to 5 years, disproportionately affecting lower- and middle-income countries.
Tianjing Hu, David F. Miller, Amber W. Taylor, Christine Riley, Caitlin McCormick, Keely N. Thomas, Rachel Y. Gao, Kathy L. Rowlen, Emilia B. Byrne, Pardeep Kumar, Soo Kyung Kim, Erica D. Dawson   +11 more
doaj   +1 more source

Possible Cross-Reactivity between SARS-CoV-2 Proteins, CRM197 and Proteins in Pneumococcal Vaccines May Protect Against Symptomatic SARS-CoV-2 Disease and Death

Vaccines, 2020
Various studies indicate that vaccination, especially with pneumococcal vaccines, protects against symptomatic cases of SARS-CoV-2 infection and death.
Robert Root-Bernstein
doaj   +1 more source

Pneumococcal vaccine and opsonic pneumococcal antibody [PDF]

Journal of Infection and Chemotherapy, 2013
Streptococcus pneumoniae is a major human pathogen responsible for the majority of bacterial pneumonia cases as well as invasive pneumococcal diseases with high mortality and morbidity. Use of conjugate vaccines targeting the pneumococcal capsule has dramatically reduced the incidence of invasive diseases, and there are active efforts to further ...
Joon Young, Song, M Allen, Moseley, Robert L, Burton, Moon H, Nahm   +3 more
openaire   +2 more sources

Pneumococcal Vaccines

Indian Journal of Medical Microbiology, 2018
Streptococcus pneumoniae continues to take a heavy toll on childhood mortality and morbidity across the developing world. An estimated 10.6 million invasive pneumococcal diseases (IPDs) occur every year, with nearly 1 million deaths in children under 5 years of age. Introduction of vaccines in the childhood immunisation programme in developed world has
Anand, Manoharan, Ranjith, Jayaraman
openaire   +2 more sources

Should Pneumococcal Vaccines Eliminate Nasopharyngeal Colonization?

mBio, 2016
Streptococcus pneumoniae remains an important human pathogen. For more than 100 years, there have been vaccine efforts to prevent pneumococcal infection. The pneumococcal conjugate vaccines have significantly reduced invasive disease.
Larry S. McDaniel, Edwin Swiatlo
doaj   +1 more source

The remarkable history of pneumococcal vaccination: an ongoing challenge

Pneumonia, 2022
Although it varies with age and geographical distribution, the global burden of infection with Streptococcus pneumoniae (pneumococcus) remains considerable.
Daniel M. Musher, Ronald Anderson, Charles Feldman   +2 more
doaj   +1 more source